Tuesday, November 16, 2010
Viamin C, cancer and S 510
S 510 and Cancer
By Jeremy Lasko
High dose Vitamin C’s impact on a man in New Zealand is stunning and wonderful news being heard around the world. The behavior of the hospitals and medical establishment, on the other hand, is causing outrage.
In August 2010, 60 Minutes reported on Intravenous Vitamin C curing a New Zealander’s swine flu just as life support was to be terminated. Dairy farmer Allan Smith had been in the hospital for weeks. Doctors felt certain he would die and wanted to take him off life support. This dramatic 18-minute report shows his “clouded out” lungs indicating “white out pneumonia”:
Despite doctor disbelief in Vitamin C efficacy, the family finally convinced them to treat Smith with high-dose IV Vitamin C. This is what his lungs looked like after two days of treatment:
The show reveals that when doctors stopped the high dose Vitamin C treatment, he deteriorated. Again, the treatment was started, and again he improved. But doctors later reduced his Vitamin C intake from 50 grams a day to 2 grams a day. His recovery reduced to a snail’s pace. Finally, the family directly provided Smith with Lyposomal-Encapsulated Vitamin C orally, and his recovery became complete, well ahead of predictions.
In 2006, the National Institutes of Health confirmed Vitamin C’s efficacy in treating cancer, something Linus Pauling attempted to share with the world decades ago, for which he was attacked, rather than lionized.
“We found 3 well-documented cases of advanced cancers, confirmed by histopathologic review, where patients had unexpectedly long survival times after receiving high-dose intravenous vitamin C therapy. We examined clinical details of each case in accordance with National Cancer Institute (NCI) Best Case Series guidelines. Tumour pathology was verified by pathologists at the NCI who were unaware of diagnosis or treatment. In light of recent clinical pharmacokinetic findings and in vitro evidence of anti-tumour mechanisms, these case reports indicate that the role of high-dose intravenous vitamin C therapy in cancer treatment should be reassessed.” [Emphasis added.]
Yet S 510 and S 3767, “food safety” bills in the US and C-36, a “product safety” bill in Canada, would remove access to this treatment and to all supplements in adequate enough doses to treat disease.
Even prior to the “food safety” bills, the FDA has been working for years to remove information on the scientific value of supplements, even very recently threatening health stores and websites that they may not even mention the word “flu” or “H1N1″ in advising customers about what products could be helpful.
The American Medical Association has arranged medical coding so doctors cannot use supplements as therapies for diseases, no matter how confirmed in studies, without potentially facing prison.
Why has the government been mute about this cheap, gentle, effective treatment for cancers? Why is it trying to get rid of a superior treatment for cancer?
How does it work?
All diseases, infections, toxins and viruses cause illness by depleting electron flow, says Dr. Thomas E. Levy, a cardiologist and lawyer. Vitamin C adds to electron flow and if it can reach the toxin, infection, or the pro-oxidant disease process in high enough concentration, any toxic or disease condition will be neutralized. Though other nutrients can add to flow, Vitamin C is the ideal choice for this because it is extremely and uniquely “bioavailable.”
Perhaps unaware that S 510 and S 3767 would remove access to it and to adequate levels of every kind of nutritional supplement, national media has begun doing segments on IV Vitamin C, recognized now as an increasingly relied upon cancer therapy...
The Senate is expected to vote on S 510 this week. Call and email your Senators to urge their opposition to the bill. Talking points can be found here, and more background on S 510 is here.
Go here for more images and videos: